[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-346479-105":59,"doc-detail-346479-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","tirank-prioritizes-phenotypic-niches-in-tumor-microenvironment-for-clinical-biomarker-discovery","TiRank prioritizes phenotypic niches in tumor microenvironment for clinical biomarker discovery","","Tumor microenvironment (TME) influences cancer progression, metastasis, and treatment response, yet selecting clinically relevant cellular subpopulations in spatial contexts from high-dimensional sparse data remains difficult. TiRank introduces a framework that uses an REO-transformation module to reduce modality biases and a multitask transfer learning strategy to align scRNA-seq, spatial transcriptomics, and bulk transcriptomes into a unified embedding. Across public datasets and pan-cancer cohorts, TiRank identifies drug-sensitive cells and clinical spatial niches, including a fibroblast-enriched tumor-boundary barrier in gastric cancer validated by multiplex protein imaging.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tirank-prioritizes-phenotypic-niches-in-tumor-microenvironment-for-clinical-biomarker-discovery/346479/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tirank-prioritizes-phenotypic-niches-in-tumor-microenvironment-for-clinical-biomarker-discovery/346479.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does TiRank address in tumor spatial biology?","Question",{"text":113,"@type":114},"TiRank targets the challenge of prioritizing clinically relevant cellular subpopulations within the tumor microenvironment using spatial and high-dimensional sparse data.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does TiRank integrate multiple omics modalities?",{"text":118,"@type":114},"TiRank combines scRNA-seq, spatial transcriptomics, and bulk transcriptomics by transforming expression using an REO module and aligning modalities into a unified embedding through multitask transfer learning.",{"name":120,"@type":111,"acceptedAnswer":121},"What was TiRank’s key example finding in gastric cancer?",{"text":122,"@type":114},"In a clinical cohort, TiRank revealed a tumor-boundary spatial niche enriched for cancer-associated fibroblasts (CAFs), linked to treatment efficacy and supported by multiplex protein imaging in an independent cohort.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},346479,1790208439,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","Lin etal. Genome Medicine (2026) 18:23  \n[https://doi.org/10.1186/s13073-026-01604-2](https://doi.org/10.1186/s13073-026-01604-2)  \nGenome Medicine  \nRESEARCH Open Access  \nTiRank prioritizes phenotypic niches in tumor  microenvironment for clinical biomarker discovery  \nYuxiang Lin1†, Zening Huang2,3†, Ziyan Lin4†, Yating Lin1,5†, Jinsheng Song4, Ling Luo1, Jiayao Chi4, Yeyang Zheng4, Youxin Gao2,3, Junjie Lin1, Xinyu Li4, Chenyu Liang1, Lei Zhang4, Xinkang Wang1, Yuqin Sun6*, Rongshan Yu1,5*, Qiyue Chen2,3* and Mengsha Tong1,4*  \nAbstract  \nBackground Tumor microenvironment (TME) plays a crucial role in cancer progression, metastasis, and treatment response. Recent advances in single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) have provided valuable insights into the cellular diversity and spatial organization of theTME. However, prioritizing clinically relevant cellular subpopulations in spatial contexts using high-dimensional and sparse data remains a challenge.  \nMethods We introduce TiRank, a novel framework designed to prioritize clinically relevant spatial niches. TiRank incorporates a relative expression ordering (REO)-transformation module to mitigate systematic biases across modalities and utilizes a multitask transfer learning framework to align scRNA-seq, ST, and bulk transcriptomes into a unified embedding space. We benchmarked TiRank using multiple public datasets and pan-cancer clinical cohorts, demonstrating its capability to identify phenotypic cell subpopulations and spatial niches.  \nResults By integrating scRNA-seq, ST, and bulk transcriptomics with clinical phenotypes, TiRank demonstrates high accuracy in identifying drug-sensitive cells and clinically relevant spatial niches across various cancer types. As a case study, we applied TiRank to gastric cancer (GC) to prioritize spatial niches associated with patient outcomes. In our clinical cohort, TiRank successfully revealed a distinct spatial niche at the tumor boundary, characterized by an enrichment of cancer-associated fibroblasts (CAFs) . This niche was associated with the efficacy of different treatment regimens. To validate this finding, we further performed multiplex protein imaging on an independent cohort to confirm the spatial distribution of the CAFs-enriched barrier. Moreover, this barrier, termed Fibro-Bar, was strongly  \n†Yuxiang Lin, Zening Huang, Ziyan Lin andYating Lin contributed equally to this work.  \n*Correspondence:  \nYuqin Sun [sunyuqin2017@163.com](sunyuqin2017@163.com)[ ](sunyuqin2017@163.com)RongshanYu [rsyu@xmu.edu.cn](rsyu@xmu.edu.cn)[ ](rsyu@xmu.edu.cn)Qiyue Chen[chenqiyue@fjmu.edu.cn](chenqiyue@fjmu.edu.cn)[ ](chenqiyue@fjmu.edu.cn)Mengsha Tong [mstong@xmu.edu.cn](mstong@xmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLin et al. Genome Medici","cbCaif7y3CGKakLF","https://ap.wps.com/l/cbCaif7y3CGKakLF","pdf",9020732,27,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n## Keywords\n## Background","[{\"question\":\"What problem does TiRank address in tumor spatial biology?\",\"answer\":\"TiRank targets the challenge of prioritizing clinically relevant cellular subpopulations within the tumor microenvironment using spatial and high-dimensional sparse data.\"},{\"question\":\"How does TiRank integrate multiple omics modalities?\",\"answer\":\"TiRank combines scRNA-seq, spatial transcriptomics, and bulk transcriptomics by transforming expression using an REO module and aligning modalities into a unified embedding through multitask transfer learning.\"},{\"question\":\"What was TiRank’s key example finding in gastric cancer?\",\"answer\":\"In a clinical cohort, TiRank revealed a tumor-boundary spatial niche enriched for cancer-associated fibroblasts (CAFs), linked to treatment efficacy and supported by multiplex protein imaging in an independent cohort.\"}]","TiRank prioritizes phenotypic niches in tumor microenvironment for clinical biomarker discovery | PDF",1790061628,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b44c7a7f2f10721057cbe9b3462545f.webp",983,1310,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b8fd123749049e5b63e7ed5755d88d8f.webp",982,1309,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/42e16cf9286a07592e9eb81fed4b62a5.webp",981,1308,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d6a633a1050ece121b210592f973c75.webp",980,1306]